Literature DB >> 7506020

The effect of incisional infiltration of bupivacaine upon pain and respiratory function following open cholecystectomy.

W C Russell1, A H Ramsay, D R Fletcher.   

Abstract

A controlled, prospective, double-blind trial of wound infiltration with bupivacaine in elective open cholecystectomy was performed to determine if this was an effective method of pain relief and reduced respiratory complications. Additionally, dextran was added to the bupivacaine in an attempt to prolong the effect. The solutions used were, bupivacaine alone 0.25% (n = 14), bupivacaine 0.25% with dextran 70 (n = 16) and saline (n = 16) as a control. To determine the effect of each solution, the subjects were assessed for pain perception and respiratory function before and after surgery. Pain was assessed using a visual analogue scale and narcotic usage, and respiratory function was assessed by spirometry, chest X-rays and arterial blood gases. The study did not demonstrate any objective improvement in either pain relief or respiratory function. This may reflect inadequate infiltration by the surgeons in the study or that infiltration should have been performed prior to incision.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 7506020     DOI: 10.1111/j.1445-2197.1993.tb00336.x

Source DB:  PubMed          Journal:  Aust N Z J Surg        ISSN: 0004-8682


  2 in total

1.  The ON-Q pain management system in elective gynecology oncologic surgery: Management of postoperative surgical site pain compared to intravenous patient-controlled analgesia.

Authors:  Dawn Chung; Yoo Jin Lee; Mi Hyun Jo; Hyun Jong Park; Ga Won Lim; Hanbyoul Cho; Eun Ji Nam; Sang Wun Kim; Jae Hoon Kim; Young Tae Kim; Sunghoon Kim
Journal:  Obstet Gynecol Sci       Date:  2013-03-12

2.  Does rectus sheath infusion of bupivacaine reduce postoperative opioid requirement?

Authors:  J Padmanabhan; A Rohatgi; A Niaz; E Chojnowska; K Baig; W G A Woods
Journal:  Ann R Coll Surg Engl       Date:  2007-04       Impact factor: 1.891

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.